Sprimeo i kombination med angiotensinreceptor- antagonisten valsartan viste en additiv blodtrykssænkende effekt i et studie specifikt designet til at undersøge effekten af kombinationsterapien.
Sprimeo in combination with the angiotensin receptor antagonist valsartan showed an additive antihypertensive effect in the study specifically designed to investigate the effect of the combination therapy.